Alpha 2.0
Login Register
» Authors » J Rello

J Rello

Explore the profile of J Rello including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 200
Citations 2733
Followers 0
Related Specialties
Infectious Diseases
Critical Care
General Medicine
Top 10 Co-Authors
J Valles
A Net
G Prats
P Coll
E Diaz
E Quintana
M Ricart
D Mariscal
V Ausina
B Mirelis
Published In
Med Intensiva
Med Clin (Barc)
Clin Microbiol Infect
Enferm Infecc Microbiol Clin
Eur J Clin Microbiol Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Rello J, Ricart M, Rodriguez A
Med Intensiva . 2024 Apr; 27(6):404-405. PMID: 38620145
No abstract available.
2.
Optimization of antimicrobial prescription in the hospital
Vieceli T, Rello J
Eur J Intern Med . 2022 Sep; 106:39-44. PMID: 36100471
Internal Medicine wards are an appropriate focus of antibiotic stewardship, along with emergency departments and intensive care units, because a large proportion of patients are with parenteral broad-spectrum antibiotics. Given...
3.
COVID-19 cutaneous manifestations in pediatric patients: 24 multisystem inflammatory syndrome in children and six Kawasaki disease cases
Tammaro A, Karim D, Adebanjo G, Parisella F, Chello C, Salih A, et al.
J Eur Acad Dermatol Venereol . 2021 Nov; 36(3):e180-e182. PMID: 34807486
No abstract available.
4.
Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2
McIntosh E, Feemster K, Rello J
Hum Vaccin Immunother . 2021 Aug; 18(1):1-7. PMID: 34406914
There is a paucity of evidence linking pneumococcal infection and influenza with SARS-CoV-2 and COVID-19. There is circumstantial evidence of the possibility of an association between and SARS-CoV-2 such as...
5.
Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?
Suarez-de-la-Rica A, Serrano P, De-la-Oliva R, Sanchez-Diaz P, Molinero P, Falces-Romero I, et al.
Rev Esp Quimioter . 2021 Mar; 34(4):330-336. PMID: 33764004
Objective: The susceptibility to infection probably increases in COVID-19 patients due to a combination of virusand drug-induced immunosuppression. The reported rate of secondary infections was quite low in previous studies....
6.
Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome
Tammaro A, Adebanjo G, Parisella F, Pezzuto A, Rello J
J Eur Acad Dermatol Venereol . 2020 Apr; 34(7):e306-e307. PMID: 32330340
No abstract available.
7.
Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
Rouby J, Sole-Lleonart C, Rello J
Intensive Care Med . 2020 Mar; 46(4):832. PMID: 32130461
The original version of this article unfortunately contained a mistake. There was a typographical error in Figure 1: "Nebulization time ≤ 30 min" (first light blue square) should be replaced...
8.
Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
Rouby J, Sole-Lleonart C, Rello J
Intensive Care Med . 2020 Jan; 46(4):766-770. PMID: 31915838
No abstract available.
9.
Implementation of infection control bundles in intensive care units: which parameters are applicable in low-to-middle income countries?
Alp E, Rello J
J Hosp Infect . 2018 Oct; 101(3):245-247. PMID: 30278993
No abstract available.
10.
Corrigendum to 'Assessing prediction accuracy for outcomes of ventilator-associated events and infections in critically ill children: a prospective cohort study' [Clinical Microbiology and Infection, Volume 24, Issue 7 (July 2018) Pages 732-737]
Pena-Lopez Y, Pujol M, Campins M, Lagunes L, Balcells J, Rello J
Clin Microbiol Infect . 2018 Sep; 25(1):125. PMID: 30217762
No abstract available.